Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.88 USD | -1.01% | +13.16% | +4.24% |
Mar. 06 | Transcript : ESSA Pharma Inc. - Shareholder/Analyst Call | |
Mar. 06 | Norway's wealth fund pushes for more women on emerging market company boards | RE |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 416M 304M |
---|---|---|---|---|---|
Net income 2024 * | -47M -34.32M | Net income 2025 * | -72M -52.57M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-8.82
x | P/E ratio 2025 * |
-6.65
x | Employees | 50 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.72% |
Latest transcript on ESSA Pharma Inc.
1 day | -1.01% | ||
1 week | +13.16% | ||
Current month | +7.00% | ||
1 month | -14.00% | ||
3 months | -28.63% | ||
6 months | +14.67% | ||
Current year | +4.24% |
Managers | Title | Age | Since |
---|---|---|---|
David Parkinson
CEO | Chief Executive Officer | 73 | 15-06-23 |
David Wood
DFI | Director of Finance/CFO | 66 | 13-09-30 |
Peter Virsik
COO | Chief Operating Officer | - | 16-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Franklin Berger
BRD | Director/Board Member | 74 | 15-03-04 |
Sanford Zweifach
BRD | Director/Board Member | 68 | 19-07-30 |
Richard Glickman
CHM | Chairman | 65 | 10-09-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 6.88 | -1.01% | 13,725 |
24-05-02 | 6.95 | +4.98% | 16,148 |
24-05-01 | 6.62 | +2.95% | 36,659 |
24-04-30 | 6.43 | +4.72% | 10,287 |
24-04-29 | 6.14 | +0.99% | 147,501 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.24% | 304M | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- EPIX Stock